Biotech Values

[DewDiligence]

Oversulfated chondroitin sulfate, the heparin contaminant MNTA helped the FDA characterize in 2008 (#msg-28748329), is still showing up in some heparin sold in the US. This is today’s alert from the FDA and the accompanying PR from B. Braun Medical (the company whose heparin was recalled):

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm231739.htm

http://www.fda.gov/Safety/Recalls/ucm231639.htm

The continued presence of OSCS in the US heparin supply can only be good for MNTA, IMO.